Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health, Inc. (NYSE: TDOC) is described as the global leader in virtual care, and the news surrounding the company reflects its focus on virtual urgent care, integrated care programs and financial performance. Company news includes announcements about enhancements to its 24/7 Care service, participation in major healthcare investor conferences, quarterly earnings results and leadership changes.
Recent updates highlight Teladoc Health’s work to expand its flagship 24/7 Care virtual urgent care service. The company has announced new capabilities that allow licensed care providers to treat a broader range of conditions, consult with board-certified specialists during visits, support preventive care using integrated claims and Health Information Exchange data, connect members to additional Teladoc Health programs and in-network providers, and check prescription benefits in real time through its Prism care delivery platform.
Investors and analysts can also find earnings-related news, including quarterly financial results for the Integrated Care and BetterHelp segments, revenue by type and geography, and non-GAAP measures such as adjusted EBITDA. Teladoc Health regularly issues press releases about its financial outlook, cash flow, and capital structure decisions, including the establishment of a senior secured revolving credit facility.
Other news items cover corporate governance and leadership developments, such as executive transitions and Board changes, as well as Teladoc Health’s participation in industry conferences and collaborations with other virtual care technology providers. This news page aggregates these updates so readers can follow Teladoc Health’s operational, strategic and financial developments over time.
Teladoc Health (TDOC) reported Q3 2024 financial results with revenue of $640.5 million, down 3% year-over-year. The company posted a net loss of $33.3 million, or $0.19 per share, improving from a $57.1 million loss in Q3 2023. Integrated Care segment revenue grew 2% to $383.7 million, while BetterHelp segment declined 10% to $256.8 million. Adjusted EBITDA decreased 6% to $83.3 million. International revenue showed strength with 15% growth to $104.3 million, while U.S. revenue declined 6% to $536.2 million.
Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced the release date for its third quarter 2024 financial results. The results will be disclosed on Wednesday, October 30, 2024, after the market closes. Following the release, the company will host a conference call at 4:30 p.m. E.T. to review the results.
Participants can join the conference call by dialing 1-833-470-1428 (U.S.) and using the access code # 781291. International participants can find global dial-in numbers at a provided link. A live audio webcast will be available at the Teladoc Health investor relations website. A replay of the call will be accessible via webcast shortly after completion and remain available for approximately 90 days.
Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, has announced the issuance of inducement awards to three new non-executive employees. Effective October 1, 2024, these employees were granted awards of restricted stock units covering a total of 105,000 shares of Teladoc Health's common stock. The vesting schedule for these units is as follows:
- One-third of the underlying shares vest on the first anniversary of the grant date
- The remaining shares vest quarterly over the subsequent two years
These awards were approved by the Compensation Committee of Teladoc Health's Board of Directors and were granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with New York Stock Exchange Rule 303A.08.
Teladoc Health (NYSE:TDOC), a leader in virtual care, has announced an inducement award for a new employee. Terre Layton, joining as Senior Vice President of Product for BetterHelp, received 50,000 restricted stock units of Teladoc Health's common stock on September 1, 2024. The vesting schedule is structured as follows:
- One-third of the shares vest on the first anniversary of the grant date
- The remaining two-thirds vest quarterly over the subsequent two years
This award, approved by the Compensation Committee of Teladoc's Board of Directors, was granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.
Harmonic Growth Partners, a leading expansion-stage investment firm, has announced the addition of Daniel Vernic as Principal to its investment team. This move strengthens Harmonic's unique investment model that combines experienced investors with world-class technology CEOs. Daniel, based in San Francisco, brings experience from Goldman Sachs and holds an M.B.A. from the University of Virginia Darden School of Business.
Harmonic's strategy integrates seasoned investors and accomplished technology CEOs, with the founding partners having backed industry leaders like Teladoc (NASDAQ: TDOC) and Peloton (NASDAQ: PTON). The firm's CEO Partners, including Dave Yarnold and Manolo Sanchez, have collectively driven over $15B in successful exits. Harmonic's portfolio includes market leaders such as ApplyBoard, Caribou, and Electric, offering a unique value proposition to expansion-stage management teams.
Teladoc Health reported its Q2 2024 financial results, showing mixed performance across segments. Revenue decreased 2% year-over-year to $642.4 million. The company recorded a net loss of $837.7 million, including a $790 million goodwill impairment charge related to BetterHelp. Adjusted EBITDA increased 24% to $89.5 million.
The Integrated Care segment grew 5% to $377.4 million in revenue with a 17% adjusted EBITDA margin. However, the BetterHelp segment declined 9% to $265 million with a 9.6% adjusted EBITDA margin. Teladoc withdrew its full-year 2024 guidance for consolidated operations and BetterHelp, as well as its three-year outlook, citing market conditions.
Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, has announced the release of its second quarter 2024 financial results on Wednesday, July 31, 2024, after market close. The company will host a conference call to review the results at 4:30 p.m. E.T. on the same day.
Participants can join the call by dialing 1-833-470-1428 (U.S.) using access code #453227. International participants can find global dial-in numbers at a provided link. A live audio webcast will be available at Teladoc's investor relations website. A replay of the call will be accessible via webcast shortly after completion and remain available for approximately 90 days.
Teladoc Health (NYSE: TDOC) has partnered with Brightline to introduce comprehensive mental healthcare for children, adolescents, and their families. This innovative offering aims to address the critical shortage of pediatric mental health providers and overcome barriers to access. Key points include:
1. Swift, early intervention and treatment for kids and teens
2. Reduced caregiver stress
3. Promotion of healthy lifestyle habits at an early age
4. Access to specialists trained in pediatric, adolescent, and family mental health
5. Support for a wide range of conditions and mental health concerns
6. Seamless transition to broader Teladoc Health ecosystem after age 18
The partnership addresses significant challenges in pediatric mental healthcare, including provider shortages, parental uncertainty about seeking help, and difficulties in obtaining appointments. By offering this service, Teladoc Health aims to improve access and outcomes for children while alleviating the burden on parents seeking quality care.
Teladoc Health (NYSE: TDOC) is extending free, 24/7 general medical telehealth services to Texas residents affected by Hurricane Beryl. This initiative covers those displaced or unable to access medical care due to the hurricane. Residents can receive virtual consultations with licensed healthcare professionals for non-emergency illnesses by calling 855-225-5032. Services include prescription refills for non-narcotic drugs and treatment for conditions like urinary tract infections, sinus problems, respiratory infections, allergies, and more. Chief Medical Officer Dr. Vidya Raman-Tangella emphasized the importance of prioritizing health during such crises. Teladoc Health's annual disaster response includes making virtual care available at no cost during federally declared natural disasters across the U.S.
Teladoc Health (NYSE:TDOC) announced the issuance of inducement awards to two new non-executive employees, effective July 1, 2024. These awards, comprising restricted stock units covering 45,693 shares of common stock, were granted under the 2023 Employment Inducement Incentive Award Plan and approved by the Compensation Committee of the Board of Directors. The restricted stock units vest as one-third on July 1, 2025, with the remainder vesting quarterly over the following two years.